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INTRODUCTION
We recently described two monoclonal antibodies (mAbs), MANEX1A and MANEXIB, raised against the N-terminus of muscle-specific dystrophin, the muscular dystrophy protein. They both recognize the same 10-mer peptides and they both crossreact with another, non-dystrophin, protein in the brain [1] .
Although this strongly suggests that both mAbs recognize the same epitope, there may be sequence differences in the mAb hypervariable, or complementarity-determining regions (CDR), which modulate mAb affinity and specificity 12]. However, the possibility that the two hybridomas are absolutely identical, having arisen from identical progeny of a proliferative lymphocyte division in the spleen, cannot be ruled out. This uncertainty is common in hybridoma work; for example, 15 out of 19 mAbs against a central 934-amino-acid region ofdystrophin were found to recognize the same 74-amino-acid sequence and further mapping has not succeeded in separating them, although there are indications that at least two different epitopes are involved [3, 4] .
We have now investigated further the relationship between the two MANEXI mAbs by cDNA sequencing of their heavy-chain CDRs (after RT-PCR amplification of hybridoma mRNAs) and by the use of a phage display library of random peptides to identify more precisely the dystrophin amino acids which form their epitopes. Phage display libraries have become powerful tools for studying protein-protein and protein-ligand interactions of all kinds [5] . By revealing which random peptides an antibody can bind to, the method shows not only which amino acids are important for mAb binding but also what variations from the true antigen sequence can be tolerated. The method can even provide information on some types of conformational epitope [6] . We now show that both MANEX1A and MANEX1 B recognize the first three amino acids of dystrophin (Leu-TrpTrp), although they differ in the effect of adjacent amino acids on binding and in their apparent cross-reaction with unrelated peptides. The extent to which small differences in antibody specificity is reflected in CDR sequence differences cannot be predicted with any confidence. Previous studies of Ig sequences have shown that mAbs which recognize similar epitopes may have quite diverse CDR sequences [7, 8] , although, on the other hand, mAbs with the same fine specificities often do have similar CDR sequences [9] . The heavy-chain CDR sequences of MANEX1A and MANEX1B reveal three differences in CDR2 which might be wholly or partly responsible for observed differences in mAb specificity. The results provide an insight into the generation of antibody diversity in the spleen and illustrate the importance of establishing several similar antibody-producing cell lines if the fine specificity of the immune response is to be immortalized as hybridomas.
MATERIALS AND METHODS Materials
The hybridoma cell lines used, MANEXIA and MANEXIB, have been described previously [1] . The pT7Blue T-vector Selection from a phage peptide library
The 15-mer library (in the fUSE5 vector based on fd phage), sequencing primers and associated bacterial cell lines were a generous gift from Professor George P. Smith (University of Missouri, U.S.A.) and his screening protocols [5] were followed with minor modifications. All solutions were sterilized by membrane filtration or autoclaving.
Abbreviations used: CDR; complementarity-determining region; mAb; monoclonal antibody; PEG, poly(ethylene glycol); VH, heavy-chain variable region.
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Sterile 3-cm-diam. Petri dishes were coated directly with mAb (10 ,ug/ml in Tris-buffered saline; TBS: 150 mM NaCl, 50 mM Tris/HCl, pH 7.5), partially purified from ascites fluid by 50 % ammonium sulphate precipitation. After blocking with 4 % BSA in TBS and washing, an aliquot of the phage library (1.5 x 1010 transducing units) was added in 0.4 ml of TBST (0.5 % Tween 20 in TBS) and incubated for 4 h at 4°C ('bio-panning'). Bound phage was eluted with glycine/HCl, pH 2.2, amplified in E. coli strain K9 I Kan and recovered by precipitation with poly(ethylene glycol) (PEG 8000; Sigma). Two further rounds of bio-panning after amplification were performed and the final eluate was transduced into K9lKan and streaked out overnight at 37°C on LB agar plates with tetracycline (40 ,tg/ml) and kanamycin (100 ,ug/ml). Phage titres were determined as transducing units by plating out 10-fold serial dilutions of transduced K9lKan. added and incubated at 37°C for 1 h, followed by 5 min at 95 'C. The mRNA purification step may be unnecessary since PCR amplification can also be achieved with total RNA.
PCR ampliffication
The primers used to amplify mouse Ig heavy-chain variable domains (VH) were: forward 5'-tgaggagacggtgaccgtggtcccttggccccag and reverse 5'-aggt(c/g)(a/c)a(a/g)ctgcag(c/g)agtc (a/t)gg [10] . To 8 u1 of cDNA were added dNTPs (50,M), primers (0.2,uM), 10 White colonies (containing insert DNA) were screened directly by PCR using heavy-chain primers. Typically, 60-70 % of white colonies contained the 350 bp insert. Plasmid DNA was purified by lysozyme/alkaline SDS treatment and phenol/chloroform extraction and treated with 1 ,tg of DNase-free pancreatic RNase overnight at 4 'C. After a second alkali denaturation and phenol/chloroform extraction, the plasmid was redissolved in 20 #1 of water. DNA sequencing of both strands was performed using heavy-chain primers or pT7Blue forward and reverse primers (forward 5'-taatacgactcactataggg; reverse 5'-ggttttcccagtcacgacg).
RESULTS
As a precaution against the isolation of non-specific phage clones, the library was panned sequentially against an uncoated dish (blocked with BSA) and an unrelated mAb (MANDYS18 against the dystrophin rod domain [4] ) before panning against a dish coated with MANEXIA. After two further rounds of amplification and panning against MANEXIA, 14 clones which gave good sequencing data were obtained and the sequences of the 15-mer peptides being expressed by these clones are aligned with the dystrophin sequence in Figure 1 . Twelve of the 14 clones gave 10 different sequences, all of which contained the threeamino-acid sequences, LWW (eight out of 10) or VWW (two out of 10), corresponding to the first three amino acids of the musclespecific isoform of dystrophin [1] (it seems a reasonable assumption, in view of our results, that the initiator methionine in the cDNA-derived sequence is absent from dystrophin in vivo). Phage particles isolated by PEG precipitation were coated at similar titres in PBS on to microwell plates for ELISA as previously described [21] . After blocking with 4% BSA, MANEX1 mAb culture supernatants were applied at a concentration of 1/1000 and mAb binding was determined, after washing, using peroxidase-labelled rabbit anti-(mouse Ig) (DAKOpatts Ltd) and o-phenylenediamine as substrate. The figures are absorbance values at 492 nm determined with a microplate reader and the peptide numbers are those used in Figure 1 . 00 This shows that the two tryptophan residues are essential for MANEX1A binding, but a conservative substitution of Val-l for Leu-I is tolerated. There is no evidence from Figure 1 that subsequent amino acids in the dystrophin sequence play any specific role in MANEXIA binding. Since LWW is at the Nterminus of dystrophin, the frequent occurrence of structurally flexible Pro and Gly residues in the preceding amino-acid sequence of the peptides may be significant. The relative avidities of MANEXIA and MANEXIB for eight of the 12 different phage-displayed peptides were compared by ELISA ( Table 1) . The reliability of this method is illustrated by the reproducibility of the results with the two pairs of identical phage clones isolated (clones 5/6 and 7/8). MANEXIB bound to all seven peptides containing the LWW/VWW sequence. There is no evidence that the substitution of Val for Leu has any differential effect, though the presence of a preceding Tyr in clones 2 and 5/6 appears to affect MANEXIA binding adversely, but not MANEXIB binding. Two unrelated clones (13 and 14 in Figure 1) were selected from the library and these were recognized weakly by MANEXIA, but not at all by MANEXIB ( Table 1 ). The two peptides do share a three-amino-acid motif, FXXXXPA, but this is not found in dystrophin.
MANEXlA
To characterize antigen-binding sequences in the mAbs, PCR products were obtained by reverse transcription of total mRNA from MANEXIA and MANEXIB hybridoma cells and PCR amplification of cDNA using the heavy-chain variable region primers described by Orlandi et al. [10] . They were cloned directly into the pT7Blue T-tailed vector for DNA sequencing. To avoid sequence errors due to PCR misincorporation, two separate PCR reactions were performed. In the case of MANEXIA, a discrepancy between the two clones sequenced (C or A at position 166) was observed, so a third clone was sequenced to confirm the C residue. (This third clone carried a different error, T to A at position 39, and this is clearly a PCR error since it introduces a stop codon. The errors were present on both strands of the PCR products.) The two MANEXIB clones gave identical sequences. Figure 2 shows Figure 3 where they have been aligned with four of the most similar sequences found by a database search (BLASTP). The antigens recognized by these four mAbs bear little relation to dystrophin or to each other. The VH regions belong to the VH7183 gene family of Brodeur and Riblet [11] and the III D siubgroup of Kabat et al. [12] . Most of the amino-acid variations between MANEXI mAbs and the archetypal VH7183 sequence have been observed in other mAbs, including Asn-51, Leu-60, Val-74 and Asn-83. The deletion of Asp-72-Asn-73 in the third framework region appears to be a novel mutation, although deletion of Asp-72 alone has been reported previously in several mAbs [12] .
DISCUSSION
In an earlier study using overlapping synthetic 10-mer peptides, we showed that both MANEXI mAbs recognized MLWWEEVEDC and WWEEVEDCYE, but not EEVEDCYERE [1] . This showed that the two tryptophan residues are essential, but left open the question of whether any of the amino acids EEVEDC are also involved. The present results show that only the LWW sequence is involved in MANEXI binding by dystrophin. The mAbs were obtained from mice immunized with a ,-galactosidase fusion protein in which plasmid-encoded residues and the initiator Met residue (DSRGIPM) preceded the LWW sequence [1] . The peptide sequences in Table 1 contain no Met residues, suggesting that the initiator Met is removed from dystrophin post-translationally, as it is from the majority of mammalian proteins. Many of them contain the preceding Pro, however, and peptides 5/6 also have a DSR sequence ( Figure 1 ). LWW is rather small for a protein epitope and this result suggests that the epitope in the fusion protein may be somewhat larger, the mAb binding to dystrophin being a reaction with only part of the epitope (although clearly the most important part). One might expect such mAbs to be uncommon and, indeed, only one out of three mice which gave a strong antibody response to the fusion protein produced antibodies which could recognize authentic dystrophin on Western blots and frozen muscle sections [1] . The possibility that the proline is merely providing a flexibility requirement to the peptides, together with nearby glycines, cannot be ruled out. The in situ accessibility of the LWW sequence in dystrophin as judged by antibody binding to air-dried, untreated, frozen muscle sections [1] , suggests that these very hydrophobic residues are not buried deeply within the dystrophin molecule, as one might
expect. An amino-acid sequence close to the N-terminus of dystrophin (only 14 amino acids after LWW) is thought to be involved in its interaction with actin [13] and this interaction might act as a constraint on the disposition of the LWW sequence.
The results in Table 1 Figure 1) . The [14] . We have not sequenced the light-chain mRNAs, so there may be more differences between the two mAbs than our results show. Of the heavy-chain CDRs, CDR3 is the most variable and is thought to make the greatest contribution to antibody specificity [15] . It is significant, therefore, that both MANEXI mAbs share the same CDR3 sequence which is different from all other CDR3s in the sequence databases. In 10 antibody-antigen complexes of known three-dimensional structure, only residues from the N-terminal and central parts Qf CDR2 are involved in antigen binding, suggesting that, of the three amino acid differences between MANEXIA and MANEXIB, the substitution of Asn-52 for Ser-52 is likely to have the greatest effect on antibody avidity and specificity; this is a contact residue in eight of the 10 three-dimensional structures determined [2] . Some comment is required on the notable sequence similarity with an mAb against influenza virus haemagglutinin ( Figure 3) . First, it is not unusual for mAbs to crossreact with apparently unrelated antigens; in this case, crossreactivity has not been tested. Secondly, their light-chain CDR sequences, which are not available, may differ more significantly than their heavy-chain CDRs. Finally, both MANEXI mAbs have a deletion of Asp-Asn (DN) in the third framework region ( Figure 3 ) and this Asn residue is known to form contacts with CDRs in some mAbs and to affect their conformation [2] . Since such contacts can influence CDR topography and hence ligand binding, this deletion may play a role in determining the specificity of the MANEXI mAbs.
Because only minor sequence differences, if any, are expected between mAbs with similar, if not identical, specificities, it is especially important to ensure that there are no errors in cDNA sequencing. PCR does introduce errors, though their frequency is affected by the type of polymerase and the reaction conditions [16] . Direct sequencing of PCR products is possible and has the advantage of helping to eliminate errors by producing an 'average' sequence for all the PCR product molecules. We elected to clone PCR products into a T-overhang vector, pT7Blue, which enables rapid and reproducible sequencing using unlabelled primers from the pT7Blue sequence, and to sequence at least two clones from separate PCR reactions in order to eliminate possible PCR errors. Provided PCR errors are both fairly uncommon and fairly random, the chance of two clones from different PCR reactions containing the same PCR error is extremely low.
It is intriguing that recent advances in understanding B-cell maturation enable us to envisage how the MANEXIA and MANEXIB hybridomas are likely to have diverged within the same B-cell lineage. In germinal centres, only B cells with highaffinity antibodies, refined by somatic mutation, are selected for Ig class-switching from IgM to another subtype and maturation as plasma or memory B cells [14] . The question of how many identical B cells (i.e. with identical variable region sequences) can accumulate in the spleen, especially under conditions of secondary stimulation used for hybridoma production, is difficult to address, but is clearly relevant to how frequently identical mAbs will be obtained. From a practical point of view, the results appear to justify our policy of producing and cloning large numbers (20) (21) (22) (23) (24) (25) of hybridomas for each immunogen [4, 17, 18] , if there are small differences in avidity and specificity between individual mAbs mapping to the same epitope.
